glp 1 and hypertension GLP-1 Agonists Blood Pressure: A Review of the Evidence | Current Reports GLP-1R and Diabetes
Description
10.1152/physrev.00034.2006 57 HolstJ
This widespread receptor distribution provides a mechanistic basis for the multifaceted effects of GLP-1 RAs on BP reduction (Figure 1)
Retrieved 16 October 2024
These prior studies were published in Diabetes Research and Clinical Practice (2020) and Diabetes, Obesity & Metabolism (2017)
The Wegovy pill and all currently available injectable versions of the drug are peptides, or short chains of amino acids, that are similar to the body's GLP-1, whereas Foundayo is a nonpeptide small molecule
